Cargando…

Potent antitumor effects of cell-penetrating peptides targeting STAT3 axis

To date, there are no inhibitors that directly and specifically target activated STAT3 and c-Myc in the clinic. Although peptide-based inhibitors can selectively block activated targets, their clinical usage is limited because of low cell penetration and/or serum stability. Here, we generated cell-p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aftabizadeh, Maryam, Li, Yi-Jia, Zhao, Qianqian, Zhang, Chunyan, Ambaye, Nigus, Song, Jieun, Nagao, Toshikage, Lahtz, Christoph, Fakih, Marwan, Ann, David K., Yu, Hua, Herrmann, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934871/ https://www.ncbi.nlm.nih.gov/pubmed/33491667 http://dx.doi.org/10.1172/jci.insight.136176

Ejemplares similares

Integrin α6 signaling induces STAT3-TET3-mediated hydroxymethylation of genes critical for maintenance of glioma stem cells
por: Herrmann, Andreas, et al.
Publicado: (2019)

Cationic Cell-Penetrating Peptides Are Potent Furin Inhibitors
por: Ramos-Molina, Bruno, et al.
Publicado: (2015)

Lycorine Displays Potent Antitumor Efficacy in Colon Carcinoma by Targeting STAT3
por: Wu, Song, et al.
Publicado: (2018)

Cell penetrating peptide: A potent delivery system in vaccine development
por: Hasannejad-Asl, Behnam, et al.
Publicado: (2022)

Synthesis and biological evaluation of celastrol derivatives as potent antitumor agents with STAT3 inhibition
por: Xu, Shaohua, et al.
Publicado: (2021)

An arginine-rich cell penetrating peptide contained anti-gelatinase scFv-LDM fusion protein shows potent antitumor efficacy in pancreatic cancer
por: Zhong, Genshen, et al.
Publicado: (2018)

Niraparib-induced STAT3 inhibition increases its antitumor effects
por: Zhao, Qianqian, et al.
Publicado: (2022)

Tumor-targeted silencing of the peptide transporter TAP induces potent antitumor immunity
por: Garrido, Greta, et al.
Publicado: (2019)

A Tumor-Penetrating Peptide Modification Enhances the Antitumor Activity of Thymosin Alpha 1
por: Lao, Xingzhen, et al.
Publicado: (2013)

Tumor-Penetrating Peptide Enhances Antitumor Effects of IL-24 Against Prostate Cancer
por: Yang, Jie, et al.
Publicado: (2018)

Potent Inhibition of Late Stages of Hepadnavirus Replication by a Modified Cell Penetrating Peptide
por: Abdul, Fabien, et al.
Publicado: (2012)

Designing Potent Anticancer Peptides by Aurein 1.2 Key Residues Mutation and Catenate Cell-Penetrating Peptide
por: Salarpour Garnaie, Hamta, et al.
Publicado: (2023)

FLT3-ITD confers resistance to the PI3K/Akt pathway inhibitors by protecting the mTOR/4EBP1/Mcl-1 pathway through STAT5 activation in acute myeloid leukemia
por: Nogami, Ayako, et al.
Publicado: (2015)

Cell-penetrating peptide conjugates to enhance the antitumor effect of paclitaxel on drug-resistant lung cancer
por: Duan, Ziqing, et al.
Publicado: (2017)

Potent antitumor activity of a glutamyltransferase-derived peptide via an activation of oncosis pathway
por: Fang, Cheng, et al.
Publicado: (2021)

Stat3 Inhibitor Stattic Exhibits Potent Antitumor Activity and Induces Chemo- and Radio-Sensitivity in Nasopharyngeal Carcinoma
por: Pan, Yunbao, et al.
Publicado: (2013)

Cynaropicrin Shows Antitumor Progression Potential in Colorectal Cancer Through Mediation of the LIFR/STATs Axis
por: Zheng, Dandan, et al.
Publicado: (2021)

A Mitochondria-Penetrating Peptide Exerts Potent Anti-Plasmodium Activity and Localizes at Parasites’ Mitochondria
por: Somsri, Sangdao, et al.
Publicado: (2021)

A membrane penetrating peptide aptamer inhibits STAT3 function and suppresses the growth of STAT3 addicted tumor cells
por: Borghouts, Corina, et al.
Publicado: (2012)

Peritumoral implantation of hydrogel-containing nanoparticles and losartan for enhanced nanoparticle penetration and antitumor effect
por: Shen, Haijun, et al.
Publicado: (2018)

Correction: Stat3 inhibitor stattic exhibits potent antitumor activity and induces chemo- and radio-sensitivity in nasopharyngeal carcinoma
por: Pan, Yunbao, et al.
Publicado: (2020)

MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway
por: Lee, Jen-Chieh, et al.
Publicado: (2022)

Effective Antitumor of Orally Intestinal Targeting Penetrating Peptide-Loaded Tyroserleutide/PLGA Nanoparticles in Hepatocellular Carcinoma
por: Ma, Chenjun, et al.
Publicado: (2021)

Antimicrobial peptides of the Cecropin-family show potent antitumor activity against bladder cancer cells
por: Suttmann, Henrik, et al.
Publicado: (2008)

Exploring novel and potent cell penetrating peptides in the proteome of SARS-COV-2 using bioinformatics approaches
por: Kardani, Kimia, et al.
Publicado: (2021)

The Natural-Based Antitumor Compound T21 Decreases Survivin Levels through Potent STAT3 Inhibition in Lung Cancer Models
por: Martínez-García, David, et al.
Publicado: (2019)

Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity
por: Kamerkar, Sushrut, et al.
Publicado: (2022)

Synergistic Enhancement of Antitumor Efficacy by PEGylated Multi-walled Carbon Nanotubes Modified with Cell-Penetrating Peptide TAT
por: Hu, Shanshan, et al.
Publicado: (2016)

In Silico and In Vivo Studies of a Tumor-Penetrating and Interfering Peptide with Antitumoral Effect on Xenograft Models of Breast Cancer
por: Marin, Gustavo H., et al.
Publicado: (2023)

DNA Damage Stress and Inhibition of Jak2-V617F Cause Its Degradation and Synergistically Induce Apoptosis through Activation of GSK3β
por: Nagao, Toshikage, et al.
Publicado: (2011)

Inhibition of the PI3K/Akt/GSK3 Pathway Downstream of BCR/ABL, Jak2-V617F, or FLT3-ITD Downregulates DNA Damage-Induced Chk1 Activation as Well as G2/M Arrest and Prominently Enhances Induction of Apoptosis
por: Kurosu, Tetsuya, et al.
Publicado: (2013)

PECAM-1 is involved in BCR/ABL signaling and may downregulate imatinib-induced apoptosis of Philadelphia chromosome-positive leukemia cells
por: WU, NAN, et al.
Publicado: (2012)

Tumor-Penetrating Peptides
por: Teesalu, Tambet, et al.
Publicado: (2013)

Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancers
por: Wang, Edina, et al.
Publicado: (2018)

Potent antitumor property of Allium bakhtiaricum extracts
por: Vafaee, Kosar, et al.
Publicado: (2019)

Furan-Conjugated Tripeptides as Potent Antitumor Drugs
por: Ali, Hunain, et al.
Publicado: (2020)

Antitumor activity of tripterine via cell-penetrating peptide-coated nanostructured lipid carriers in a prostate cancer model
por: Yuan, Ling, et al.
Publicado: (2013)

An optimized peptide vaccine strategy capable of inducing multivalent CD8(+) T cell responses with potent antitumor effects
por: Cho, Hyun-Il, et al.
Publicado: (2015)

A novel VEGFR inhibitor ZLF-095 with potent antitumor activity and low toxicity
por: Li, Xiao, et al.
Publicado: (2023)

Discovery of Novel Quinazoline Derivatives as Potent Antitumor Agents
por: Niu, Zhenxi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jjr8cmv170ttu0sj5f4ddvtvag